Chief Business Officer
Ton Berkien, Chief Business Officer, joined the company in 2014. He has extensive experience in business development, market intelligence and corporate finance. His most recent position was at Takeda/Nycomed, where he was acting Head of Corporate Development/M&A being responsible for several M&A transactions in the US, and Europe as well as in various Emerging Growth Markets like China, Brazil and Colombia. Prior to Takeda, he held a similar position at Nycomed Pharmaceuticals. During 2003-2007, Ton was Director of Competitive Intelligence at Ferring Pharmaceuticals, where he was responsible CI project management in both the R&D and commercial organisation. Earlier, Ton held Senior Manager positions at PricewaterhouseCoopers, Rijnconsult, KPMG and Gilde Investment Management.
Ton has a BA degree in economics from the Saxion University of Applied Science in Holland, and an LSid from PwC/Harvard Business School/IMD.
Number of shares: 1,400
Number of warrants: 138,558 warrants series 1 and 3,822 warrants series 2